Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.4B | 6.7B | 5.4B | 5.2B |
Cost of revenue | 5.1B | 6.4B | 5.2B | 5.1B |
Gross profit | 279.6M | 253.7M | 142.7M | 147.4M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 104.3M | 168.1M | 108.0M | 83.9M |
Other operating expenses | -4.7M | -55.2M | -4.1M | -21.7M |
Operating income | 179.9M | 140.8M | 38.9M | 85.2M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 19.5M | 19.3M | 20.1M | 21.7M |
Other income expense | -8.1M | -1.3M | -908K | 4.1M |
Pretax income | 152.4M | 120.2M | 17.9M | 67.5M |
Tax provision | 24.4M | -1.5M | 7.1M | 6.0M |
Net income | 128.0M | 121.7M | 10.8M | 61.5M |
Basic EPS | 0.1 | — | 0.0 | 0.0 |
Diluted EPS | 0.1 | — | 0.0 | 0.0 |
Basic average shares | 1.4B | — | 1.4B | 1.3B |
Diluted average shares | 1.4B | — | 1.4B | 1.3B |
EBITDA | 287.8M | 254.8M | 159.2M | 201.7M |
Net income from continuing op. | 128.0M | 121.7M | 10.8M | 61.5M |
Minority interests | 575K | -53.8M | -23.2M | -21.8M |
Preferred stock dividends | — | — | — | — |